Nabriva Therapeutics
NBRV
$1.42
Share price
0.00%
Change (1 day)
-71.20%
Change (1 year)
Categories
Earnings for Nabriva Therapeutics (NBRV)
Earnings in 2023 (TTM): -$52.86 M
According to Nabriva Therapeutics 's latest financial reports the company's current earnings (TTM) are -$52.86 M. In 2022 the company made an earning of -$55.62 M a decrease over its 2021 earnings that were of -$48.96 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Nabriva Therapeutics from 2014 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$52.86 M | -4.97% |
| 2022 | -$55.62 M | 13.6% |
| 2021 | -$48.96 M | -29.4% |
| 2020 | -$69.35 M | -16.11% |
| 2019 | -$82.67 M | -27.95% |
| 2018 | -$0.12 B | 57.16% |
| 2017 | -$73.01 M | 31.39% |
| 2016 | -$55.57 M | 77.75% |
| 2015 | -$31.26 M | 93.16% |
| 2014 | -$16.19 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | 109.60% | 🇺🇸 USA |